Lunai Bioworks (LNAI) vs NuCana (NCNA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Lunai Bioworks is the larger company by market cap ($5.2 million vs $4.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | LNAI | NCNA |
|---|---|---|
| Share price | $1.14 | $1.12 |
| Market cap | $5.17M | $4.67M |
| 1-day change | +4.59% | -1.61% |
| EPS (TTM) | $-61.36 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.28 | $6.40 |
| 52-week low | $1.08 | $0.948 |
| Distance from 52-week high | -91.42% | -82.47% |
| Average volume | 181.37K | 123.99K |
| Shares outstanding | 4.53M | 4.16M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
LNAI vs NCNA FAQ
Which is bigger, Lunai Bioworks or NuCana?
Lunai Bioworks (LNAI) is larger, with a market capitalization of $5.17M compared with $4.67M for NuCana (NCNA).
Are Lunai Bioworks and NuCana in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.